MicroRNA Signatures and Canine Osteosarcoma
Author Information
Author(s): Ludwig Latasha, Edson Michael, Treleaven Heather, Viloria-Petit Alicia M., Mutsaers Anthony J., Moorehead Roger, Foster Robert A., Ali Ayesha, Wood R. Darren, Wood Geoffrey A.
Primary Institution: University of Guelph, Ontario Veterinary College
Hypothesis
Can plasma microRNA signatures predict prognosis in canine osteosarcoma patients?
Conclusion
High expression of miR-214-3p in plasma is a strong predictor of poor prognosis in dogs with osteosarcoma.
Supporting Evidence
- MiR-214-3p was the only miRNA with increased expression across all OSA populations compared to controls.
- High expression of miR-214-3p predicted shorter overall survival and disease-free interval.
- Multiple miRNA models provided better outcome prediction than single miRNAs.
Takeaway
This study found that a specific molecule in the blood, called miR-214-3p, can help predict how long dogs with a certain type of bone cancer will live.
Methodology
The study analyzed plasma samples from dogs with osteosarcoma using real-time quantitative polymerase chain reaction to measure the expression of 56 miRNAs.
Potential Biases
Potential bias due to the selection of samples from different veterinary biobanks.
Limitations
The study is limited by the retrospective nature and potential variability in sample handling and storage.
Participant Demographics
Dogs diagnosed with appendicular osteosarcoma, median age 8 years, with a mix of breeds.
Statistical Information
P-Value
p<0.00001 for miR-214-3p
Confidence Interval
95% CI not specified
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website